1
|
Rainey S. An Anticipatory Approach to Ethico-Legal Implications of Future Neurotechnology. SCIENCE AND ENGINEERING ETHICS 2024; 30:18. [PMID: 38748291 PMCID: PMC11096192 DOI: 10.1007/s11948-024-00482-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Accepted: 04/20/2024] [Indexed: 05/18/2024]
Abstract
This paper provides a justificatory rationale for recommending the inclusion of imagined future use cases in neurotechnology development processes, specifically for legal and policy ends. Including detailed imaginative engagement with future applications of neurotechnology can serve to connect ethical, legal, and policy issues potentially arising from the translation of brain stimulation research to the public consumer domain. Futurist scholars have for some time recommended approaches that merge creative arts with scientific development in order to theorise possible futures toward which current trends in technology development might be steered. Taking a creative, imaginative approach like this in the neurotechnology context can help move development processes beyond considerations of device functioning, safety, and compliance with existing regulation, and into an active engagement with potential future dynamics brought about by the emergence of the neurotechnology itself. Imagined scenarios can engage with potential consumer uses of devices that might come to challenge legal or policy contexts. An anticipatory, creative approach can imagine what such uses might consist in, and what they might imply. Justifying this approach also prompts a co-responsibility perspective for policymaking in technology contexts. Overall, this furnishes a mode of neurotechnology's emergence that can avoid crises of confidence in terms of ethico-legal issues, and promote policy responses balanced between knowledge, values, protected innovation potential, and regulatory safeguards.
Collapse
Affiliation(s)
- Stephen Rainey
- Department of Values, Technology and Innovation (VTI), Delft University of Technology, Delft, The Netherlands.
| |
Collapse
|
2
|
|
3
|
Haeusermann T, Liu EY, Fong KC, Dohan D, Chiong W. Patient experiences of resection versus responsive neurostimulation for drug-resistant epilepsy. Epilepsy Behav 2024; 153:109707. [PMID: 38430673 PMCID: PMC11185832 DOI: 10.1016/j.yebeh.2024.109707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Revised: 01/17/2024] [Accepted: 02/19/2024] [Indexed: 03/05/2024]
Abstract
This study explored illness experiences and decision-making among patients with epilepsy who underwent two different types of surgical interventions: resection versus implantation of the NeuroPace Responsive Neurostimulation System (RNS). We recruited 31 participants from a level four epilepsy center in an academic medical institution. We observed 22 patient clinic visits (resection: n = 10, RNS: n = 12) and conducted 18 in-depth patient interviews (resection: n = seven, RNS: n = 11); most visits and interviews included patient caregivers. Using an applied ethnographic approach, we identified three major themes in the experiences of resection versus RNS patients. First, for patients in both cohorts, the therapeutic journey was circuitous in ways that defied standardized first-, second-, and third- line of care models. Second, in conceptualizing risk, resection patients emphasized the permanent loss of "taking out" brain tissue whereas RNS patients highlighted the reversibility of "putting in" a device. Lastly, in considering benefit, resection patients perceived their surgery as potentially curative while RNS patients understood implantation as primarily palliative with possible additional diagnostic benefit from chronic electrocorticography. Insight into the perspectives of patients and caregivers may help identify key topics for counseling and exploration by clinicians.
Collapse
Affiliation(s)
| | - Emily Yang Liu
- UCSF Weill Institute for Neurosciences, United States; UCSF Bioethics, United States; UCSF Epilepsy Center, United States.
| | - Kristina Celeste Fong
- UCSF Weill Institute for Neurosciences, United States; UCSF Bioethics, United States
| | - Daniel Dohan
- UCSF Institute for Health Policy Studies, United States
| | - Winston Chiong
- UCSF Weill Institute for Neurosciences, United States; UCSF Bioethics, United States
| |
Collapse
|
4
|
Sample M, Sattler S, Boehlen W, Racine E. Brain-computer interfaces, disability, and the stigma of refusal: A factorial vignette study. PUBLIC UNDERSTANDING OF SCIENCE (BRISTOL, ENGLAND) 2023; 32:522-542. [PMID: 36633302 PMCID: PMC10115937 DOI: 10.1177/09636625221141663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
As brain-computer interfaces are promoted as assistive devices, some researchers worry that this promise to "restore" individuals worsens stigma toward disabled people and fosters unrealistic expectations. In three web-based survey experiments with vignettes, we tested how refusing a brain-computer interface in the context of disability affects cognitive (blame), emotional (anger), and behavioral (coercion) stigmatizing attitudes (Experiment 1, N = 222) and whether the effect of a refusal is affected by the level of brain-computer interface functioning (Experiment 2, N = 620) or the risk of malfunctioning (Experiment 3, N = 620). We found that refusing a brain-computer interface increased blame and anger, while brain-computer interface functioning did change the effect of a refusal. Higher risks of device malfunctioning partially reduced stigmatizing attitudes and moderated the effect of refusal. This suggests that information about disabled people who refuse a technology can increase stigma toward them. This finding has serious implications for brain-computer interface regulation, media coverage, and the prevention of ableism.
Collapse
Affiliation(s)
- Matthew Sample
- Matthew Sample, Centre for Ethics and Law in the Life Sciences, Leibniz University Hannover, 30167 Hannover, Germany.
| | | | - Wren Boehlen
- Institut de recherches cliniques de Montréal, Canada
| | - Eric Racine
- Institut de recherches cliniques de Montréal, Canada; Université de Montréal, Canada; McGill University, Canada
| |
Collapse
|
5
|
Walker SL, Viaña JN. Mindful mindfulness reporting: Media portrayals of scientific evidence for meditation mobile apps. PUBLIC UNDERSTANDING OF SCIENCE (BRISTOL, ENGLAND) 2023:9636625221147794. [PMID: 36734473 DOI: 10.1177/09636625221147794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Abstract
Promoting mental health is a major global challenge. As mindfulness meditation apps can help maintain and restore good mental health, it is important to understand how their efficacy and safety are portrayed in the media. This study systematically evaluates whether evidence from academic research is used to communicate the health effects of two popular mindfulness apps, Calm and Smiling Mind. A scoping review mapped research findings from 16 relevant articles, and a media analysis examined the types of evidence used in news reporting. Analysing 105 news articles revealed that 98% did not use evidence from academic research on app-based meditation to support health claims. Only 28.5% of articles included advice from a health expert, and 9.5% mentioned potential risks and alternative treatments. Stronger evidence-based reporting on the health effects of mindfulness apps is needed to enable people to make more informed decisions for their health and wellbeing.
Collapse
Affiliation(s)
| | - John Noel Viaña
- Australian National University, Australia; Commonwealth Scientific and Industrial Research Organisation, Australia
| |
Collapse
|
6
|
Public attitudes towards neurotechnology: Findings from two experiments concerning Brain Stimulation Devices (BSDs) and Brain-Computer Interfaces (BCIs). PLoS One 2022; 17:e0275454. [DOI: 10.1371/journal.pone.0275454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Accepted: 09/17/2022] [Indexed: 11/10/2022] Open
Abstract
This study contributes to the emerging literature on public perceptions of neurotechnological devices (NTDs) in their medical and non-medical applications, depending on their invasiveness, framing effects, and interindividual differences related to personal needs and values. We conducted two web-based between-subject experiments (2×2×2) using a representative, nation-wide sample of the adult population in Germany. Using vignettes describing how two NTDs, brain stimulation devices (BSDs; NExperiment 1 = 1,090) and brain-computer interfaces (BCIs; NExperiment 2 = 1,089), function, we randomly varied the purpose (treatment vs. enhancement) and invasiveness (noninvasive vs. invasive) of the NTD, and assessed framing effects (variable order of assessing moral acceptability first vs. willingness to use first). We found a moderate moral acceptance and willingness to use BSDs and BCIs. Respondents preferred treatment over enhancement purposes and noninvasive over invasive devices. We also found a framing effect and explored the role of personal characteristics as indicators of personal needs and values (e.g., stress, religiosity, and gender). Our results suggest that the future demand for BSDs or BCIs may depend on the purpose, invasiveness, and personal needs and values. These insights can inform technology developers about the public’s needs and concerns, and enrich legal and ethical debates.
Collapse
|
7
|
Sensor Technology and Intelligent Systems in Anorexia Nervosa: Providing Smarter Healthcare Delivery Systems. BIOMED RESEARCH INTERNATIONAL 2022; 2022:1955056. [PMID: 36193321 PMCID: PMC9526573 DOI: 10.1155/2022/1955056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Accepted: 09/06/2022] [Indexed: 11/22/2022]
Abstract
Ubiquitous technology, big data, more efficient electronic health records, and predictive analytics are now at the core of smart healthcare systems supported by artificial intelligence. In the present narrative review, we focus on sensing technologies for the healthcare of Anorexia Nervosa (AN). We employed a framework inspired by the Interpersonal Neurobiology Theory (IPNB), which posits that human experience is characterized by a flow of energy and information both within us (within our whole body), and between us (in the connections we have with others and with nature). In line with this framework, we focused on sensors designed to evaluate bodily processes (body sensors such as implantable sensors, epidermal sensors, and wearable and portable sensors), human social interaction (sociometric sensors), and the physical environment (indoor and outdoor ambient sensors). There is a myriad of man-made sensors as well as nature-based sensors such as plants that can be used to design and deploy intelligent systems for human monitoring and healthcare. In conclusion, sensing technologies and intelligent systems can be employed for smarter healthcare of AN and help to relieve the burden of health professionals. However, there are technical, ethical, and environmental sustainability issues that must be considered prior to implementing these systems. A joint collaboration of professionals and other members of the society involved in the healthcare of individuals with AN can help in the development of these systems. The evolution of cyberphysical systems should also be considered in these collaborations.
Collapse
|
8
|
Restoring vision using optogenetics without being blind to the risks. Graefes Arch Clin Exp Ophthalmol 2021; 260:41-45. [PMID: 34724112 PMCID: PMC8558540 DOI: 10.1007/s00417-021-05477-6] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2021] [Revised: 10/12/2021] [Accepted: 10/25/2021] [Indexed: 11/25/2022] Open
Abstract
Retinit is pigmentosa is an incurable degenerative disease that causes loss of light-sensitive cells in the retina and leads to severe vision impairment. The development of optogenetics has created great hype around its potential to treat retinitis pigmentosa by the introduction of light-sensitive proteins into other neural cells in the retina. The first-in-human studies of optogenetic treatment for this disease have recently been reported (NCT02556736 and NCT03326336). The treatment involves irreversible gene therapy and requires access to specially designed goggles to deliver light to the treated eye. These highly innovative and high-profile clinical trials raise numerous ethical issues that must be addressed during the early phases of research and clinical testing to ensure trial participants are treated fairly and can provide appropriate informed consent.
Collapse
|
9
|
Gilbert F, Lancelot M. Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a 'new form of the disease'. JOURNAL OF MEDICAL ETHICS 2021; 47:20-25. [PMID: 32409626 DOI: 10.1136/medethics-2019-106052] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/26/2019] [Revised: 04/14/2020] [Accepted: 04/15/2020] [Indexed: 06/11/2023]
Abstract
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) in 1997. It is estimated that more than 150 000 patients have been implanted, with a forecasted rapid increase in uptake with population ageing. Recent longitudinal follow-up studies have reported a significant increase in postoperative survival rates of patients with PD implanted with DBS as compared with those not implanted with DBS. Although DBS tends to increase life expectancy for most patients with PD, this medical benefit does not come without attendant negative consequences. For example, emerging forms of iatrogenic harms are sometimes induced-harms which were not initially expected when clinicians proposed neurosurgery and patients or their guardians consented to the treatment. We report and discuss the clinical case of a patient who was implanted with DBS more than 20 years ago (at the time of writing) and is now experiencing unexpected stages of PD. This case illustrates how extending the life span without improving quality of life may introduce a burden of harms for patients and families. As well, this case shows why we should prepare for the expanding numbers of PD-implanted patients experiencing a gain of longevity but with severe stages of disease leading to diminution in quality of life. This newly observed effect of DBS treatment requires us to explore ethical questions related to iatrogenic harms, informed consent, end of life and caregivers' burden.
Collapse
Affiliation(s)
- Frederic Gilbert
- School of Humanities, University of Tasmania, Hobart, Tasmania, Australia
- Center for Neurotechnology, University of Washington, Seattle, U.S.A
| | - Mathilde Lancelot
- SPHERE, Paris Diderot University / University of Paris, Paris, France
| |
Collapse
|
10
|
Sustainable Digital Transformation of Disaster Risk—Integrating New Types of Digital Social Vulnerability and Interdependencies with Critical Infrastructure. SUSTAINABILITY 2020. [DOI: 10.3390/su12229324] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
This article explores the relationship between digital transformation and disaster risk. Vulnerability studies aim at differentiating impacts and losses by using fine-grained information from demographic, social, and personal characteristics of humans. With ongoing digital development, these characteristics will transform and result in new traits, which need to be identified and integrated. Digital transformations will produce new social groups, partly human, semi-human, or non-human—some of which already exist, and some which can be foreseen by extrapolating from recent developments in the field of brain wearables, robotics, and software engineering. Though involved in the process of digital transformation, many researchers and practitioners in the field of Disaster Risk Reduction or Climate Change Adaptation are not yet aware of the repercussions for disaster and vulnerability assessments. Emerging vulnerabilities are due to a growing dependency on digital services and tools in the case of a severe emergency or crisis. This article depicts the different implications for future theoretical frameworks when identifying novel semi-human groups and their vulnerabilities to disaster risks. Findings include assumed changes within common indicators of social vulnerability, new indicators, a typology of humans, and human interrelations with digital extensions and two different perspectives on these groups and their dependencies with critical infrastructure.
Collapse
|
11
|
Gilbert F, Brown, Dasgupta, Martens, Klein, Goering. An Instrument to Capture the Phenomenology of Implantable Brain Device Use. NEUROETHICS-NETH 2019. [DOI: 10.1007/s12152-019-09422-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
|